Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway.
Advances in the pharmacological and neurological treatment of patients with multiple sclerosis.
Vitamin D, steroid hormones, and autoimmunity.
Monitoring game-based motor rehabilitation of patients at home for better plans of care and quality of life.
Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis.
Autoimmune priming tissue attack and chronic inflammation - The three stages of rheumatoid arthritis.
Hospital admission due to infections in multiple sclerosis patients.
High prevalence of sickness absence and disability pension among multiple sclerosis patients: a nationwide population-based study.
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells.
Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.
Intrathecal immune reset in multiple sclerosis: Exploring a new concept.
Development and validation of the Dutch version of the London Handicap Scale.
Attributional style and depression in multiple sclerosis: the learned helplessness model.
Resting-State fMRI in MS: General Concepts and Brief Overview of Its Application.
Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.
Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.
The efficacy and safety of daclizumab and its potential role in the treatment of multiple sclerosis.
[Physiotherapy and neurogenic lower urinary tract dysfunction in multiple sclerosis patients: A randomized controlled trial].
TRANSGLUTAMINASE 2 IS INVOLVED IN HOMOCYSTEINE-INDUCED ACTIVATION OF HUMAN THP-1 MONOCYTES.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
Feasibility of Cell Therapy in Multiple Sclerosis: A Systematic Review of 83 Studies.
Autonomic Dysregulation in Multiple Sclerosis.
Neuropharmacological Actions of Metformin in Stroke.
Adrenergic regulation of innate immunity: a review.

Pages